Scribe Therapeutics, Inc. (SCTX) has 6 open-market insider trades by 6 insiders since 2026. Over the last six months insiders net bought $71.3M. The most active filer is Behzad Aghazadeh, Director & 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Behzad Aghazadeh | Dir10% Owner | — | 1 | $36.3M | 2026-07-28 |
| Orbimed Advisors LLC | Dir | — | 1 | $15.0M | 2026-07-27 |
| Carl L. Gordon | Dir | — | 1 | $15.0M | 2026-07-27 |
| AH Bio Fund II, L.P. | 10% Owner | — | 1 | $5.0M | 2026-07-27 |
| Svetlana Lucas | — | — | 1 | $45K | 2026-07-23 |
| David Parrot | CFO | — | 1 | $20K | 2026-07-23 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Orbimed Advisors LLC | Director | Buy | $15.0M | 2026-07-27 |
| AH Bio Fund II, L.P. | 10% Owner | Buy | $5.0M | 2026-07-27 |
| Behzad Aghazadeh | Director & 10% Owner | Buy | $36.3M | 2026-07-24 |
| Svetlana Lucas | — | Buy | $45K | 2026-07-23 |
| David Parrot | CFO | Buy | $20K | 2026-07-23 |
Companies that share insiders with SCTX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.